Invention Grant
- Patent Title: Endoplasmic reticulum localization signals
-
Application No.: US14850990Application Date: 2015-09-11
-
Publication No.: US09617317B2Publication Date: 2017-04-11
- Inventor: Thomas D. Reed
- Applicant: Intrexon Corporation
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A01K67/027 ; C12N15/62 ; C12N15/85 ; C07K2/00

Abstract:
The invention relates to cellular localization signals. In particular, the invention relates to endoplasmic reticulum localization signals in monomeric or multimeric form. The localization signals are utilized as research tools or are linked to therapeutics. Disclosed are methods of making and using polypeptides and modified polypeptides as signals to localize therapeutics, experimental compounds, peptides, proteins and/or other macromolecules to the endoplasmic reticulum of eukaryotic cells. The polypeptides of the invention optionally include linkage to reporters, epitopes and/or other experimental or therapeutic molecules. The invention also encompasses polynucleotides encoding the localization signals and vectors comprising these polynucleotides.
Public/Granted literature
- US20160060308A1 Endoplasmic Reticulum Localization Signals Public/Granted day:2016-03-03
Information query